USD 16.94
(-5.88%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 | 41.99 Billion JPY | 27.35% |
2023 | 32.97 Billion JPY | 24.4% |
2022 | 26.5 Billion JPY | -29.3% |
2021 | 37.49 Billion JPY | 6.62% |
2020 | 35.16 Billion JPY | 116.85% |
2019 | 16.21 Billion JPY | 231.28% |
2018 | -12.35 Billion JPY | 24.25% |
2017 | -16.3 Billion JPY | -212.77% |
2016 | -5.21 Billion JPY | -190.93% |
2015 | 5.73 Billion JPY | 353.28% |
2014 | 1.26 Billion JPY | -43.63% |
2013 | 2.24 Billion JPY | -88.37% |
2012 | 19.3 Billion JPY | 286.38% |
2011 | -10.35 Billion JPY | 16.62% |
2010 | -12.41 Billion JPY | -1.24% |
2009 | -12.26 Billion JPY | 13.9% |
2008 | -14.24 Billion JPY | -1.73% |
2007 | -14 Billion JPY | 3.13% |
2006 | -14.45 Billion JPY | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 FY | 41.99 Billion JPY | 27.35% |
2024 Q2 | 26.9 Billion JPY | -19.84% |
2024 Q1 | 33.56 Billion JPY | 1.78% |
2024 Q4 | 41.99 Billion JPY | 41.42% |
2024 Q3 | 29.69 Billion JPY | 10.39% |
2023 Q3 | 26.21 Billion JPY | 43.79% |
2023 Q1 | 15.78 Billion JPY | -40.47% |
2023 Q4 | 32.97 Billion JPY | 25.78% |
2023 FY | 32.97 Billion JPY | 24.4% |
2023 Q2 | 18.23 Billion JPY | 15.54% |
2022 Q1 | 26.64 Billion JPY | -28.93% |
2022 Q3 | 15.58 Billion JPY | -28.55% |
2022 FY | 26.5 Billion JPY | -29.3% |
2022 Q2 | 21.81 Billion JPY | -18.14% |
2022 Q4 | 26.5 Billion JPY | 70.1% |
2021 Q3 | 26.69 Billion JPY | -26.46% |
2021 Q1 | 45.56 Billion JPY | 29.58% |
2021 Q4 | 37.49 Billion JPY | 40.44% |
2021 Q2 | 36.3 Billion JPY | -20.33% |
2021 FY | 37.49 Billion JPY | 6.62% |
2020 Q4 | 35.16 Billion JPY | 11.53% |
2020 FY | 35.16 Billion JPY | 116.85% |
2020 Q1 | 20.69 Billion JPY | 27.64% |
2020 Q2 | 26.16 Billion JPY | 26.38% |
2020 Q3 | 31.53 Billion JPY | 20.54% |
2019 Q1 | -3.97 Billion JPY | 67.85% |
2019 Q2 | -3.5 Billion JPY | 11.88% |
2019 Q4 | 16.21 Billion JPY | 57.19% |
2019 FY | 16.21 Billion JPY | 231.28% |
2019 Q3 | 10.31 Billion JPY | 394.77% |
2018 Q2 | -20.87 Billion JPY | -12.73% |
2018 FY | -12.35 Billion JPY | 24.25% |
2018 Q4 | -12.35 Billion JPY | 45.02% |
2018 Q3 | -22.46 Billion JPY | -7.65% |
2018 Q1 | -18.51 Billion JPY | -13.54% |
2017 Q2 | -9.93 Billion JPY | -33.57% |
2017 FY | -16.3 Billion JPY | -212.77% |
2017 Q3 | -13.2 Billion JPY | -32.97% |
2017 Q1 | -7.43 Billion JPY | -42.62% |
2017 Q4 | -16.3 Billion JPY | -23.48% |
2016 Q2 | -2.08 Billion JPY | -174.25% |
2016 Q4 | -5.21 Billion JPY | 7.41% |
2016 Q3 | -5.63 Billion JPY | -169.68% |
2016 FY | -5.21 Billion JPY | -190.93% |
2016 Q1 | 2.81 Billion JPY | -50.96% |
2015 Q2 | -5.66 Billion JPY | 9.66% |
2015 Q1 | -6.27 Billion JPY | -595.97% |
2015 Q3 | -10.04 Billion JPY | -77.15% |
2015 Q4 | 5.73 Billion JPY | 157.11% |
2015 FY | 5.73 Billion JPY | 353.28% |
2014 Q1 | 269 Million JPY | -88.01% |
2014 FY | 1.26 Billion JPY | -43.63% |
2014 Q3 | -852 Million JPY | 63.32% |
2014 Q4 | 1.26 Billion JPY | 248.47% |
2014 Q2 | -2.32 Billion JPY | -963.57% |
2013 Q3 | 9.09 Billion JPY | -12.44% |
2013 Q4 | 2.24 Billion JPY | -75.32% |
2013 FY | 2.24 Billion JPY | -88.37% |
2013 Q1 | 15.63 Billion JPY | -18.98% |
2013 Q2 | 10.38 Billion JPY | -33.58% |
2012 FY | 19.3 Billion JPY | 286.38% |
2012 Q2 | -14.68 Billion JPY | 5.0% |
2012 Q3 | 23.82 Billion JPY | 262.3% |
2012 Q4 | 19.3 Billion JPY | -19.0% |
2012 Q1 | -15.45 Billion JPY | -49.24% |
2011 Q1 | -14.86 Billion JPY | -19.66% |
2011 FY | -10.35 Billion JPY | 16.62% |
2011 Q2 | -15.49 Billion JPY | -4.29% |
2011 Q3 | -14.32 Billion JPY | 7.54% |
2011 Q4 | -10.35 Billion JPY | 27.73% |
2010 Q2 | -17.66 Billion JPY | 0.0% |
2010 FY | -12.41 Billion JPY | -1.24% |
2010 Q4 | -12.41 Billion JPY | 4.21% |
2010 Q3 | -12.96 Billion JPY | 26.61% |
2009 Q3 | -16.27 Billion JPY | 0.0% |
2009 Q4 | -12.26 Billion JPY | 24.63% |
2009 FY | -12.26 Billion JPY | 13.9% |
2008 FY | -14.24 Billion JPY | -1.73% |
2007 FY | -14 Billion JPY | 3.13% |
2006 FY | -14.45 Billion JPY | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
American Bio Medica Corporation | 2.2 Million USD | -1903753.128% |
Arrayit Corporation | 1.05 Million USD | -3978660.492% |
Atlantic International Corp. | 236.49 Thousand USD | -17758762.729% |
Biocept, Inc. | -788 Thousand USD | 5329922.335% |
Bioqual, Inc. | -12 Million USD | 349884.565% |
CardioGenics Holdings Inc | 22.73 Thousand USD | -184700194.648% |
DermTech, Inc. | 17.65 Million USD | -237814.236% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 7436.176% |
HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 569430.596% |
iMD Companies, Inc. | 1.11 Million USD | -3763541.284% |
IDenta Corp. | 524.85 Thousand USD | -8001965.344% |
Interpace Biosciences, Inc. | 7.69 Million USD | -545766.909% |
Integrative Health Technologies, Inc. | -26.95 Thousand USD | 155828980.974% |
InVitro International | -313.14 Thousand USD | 13412226.128% |
Lumos Diagnostics Holdings Limited | 1.56 Million USD | -2681975.772% |
Many Bright Ideas Technologies Inc. | -713.00 USD | 5890462933.1% |
Medical Imaging Corp. | 3.79 Million USD | -1107779.718% |
NovelStem International Corp. | 3.52 Million USD | -1192532.987% |
Optigenex Inc. | 8.93 Million USD | -470004.135% |
PharmChem, Inc. | -1.49 Million USD | 2810501.141% |
Proteome Sciences plc | 14.57 Million USD | -288091.339% |
Response Genetics, Inc | -13.08 Million USD | 321046.049% |
Rennova Health, Inc. | 14.82 Million USD | -283105.316% |
RushNet, Inc. | 4.8 Million USD | -874725.161% |
ScreenPro Security Inc. | 135.58 Thousand USD | -30975126.604% |
Stella Diagnostics Inc. | 6.19 Million USD | -678062.44% |
StageZero Life Sciences Ltd. | 1.78 Million USD | -2353577.625% |
Todos Medical Ltd. | 38.31 Million USD | -109517.894% |